Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aina Arbusà
Observed names:
A. Arbusa,
Aina Arbusà Roca,
Aina Arbusà-Roca
Institution:
Vall d'Hebron Institute of Oncology
Observed institutions:
The Netherlands Cancer Institute,
Institut Català d'Oncologia,
Oncode Institute,
Institut d'Investigació Biomèdica de Girona,
Vall d'Hebron Hospital Universitari,
Vall d'Hebron Institute of Oncology
show all 6
ORCID:
0000-0002-7053-7386
Observed ORCID:
0000-0002-7053-7386
OpenAlex ID:
A5053302018
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells
2021
·
Barbara Schroeder
, Travis Vander Steen
, et al.
·
Cell Death and Disease
·
121
PDF
Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence
2021
·
Apostolos Menegakis
, Rob Klompmaker
, et al.
·
Cells
·
45
PDF
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
2021
·
Angela Tramonti
, Elisabet Cuyàs
, et al.
·
Cancers
·
31
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
2024
·
Valeria Sebri
, Chiara Marzorati
, et al.
·
Cancer Medicine
·
29
PDF
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin
2021
·
Joaquim Bosch-Barrera
, Ariadna Roqué
, et al.
·
Pharmaceuticals
·
8
PDF
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
2026
·
Arsela Prelaj
, Vanja Miskovic
, et al.
·
Nature Medicine
·
4
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
2026
·
Ilaria Priano
, Ramon Amat
, et al.
·
Genome Medicine
417P Benchmarking digital pathology foundation models on PD-L1 slides for immunotherapy response classification
2025
·
A. Zec
, E. Lombardo Facciale
, et al.
·
ESMO Real World Data and Digital Oncology
P2.06.65 An Ensemble Approach to Predict Three-Class PD-L1 Expression From H&E Whole-Slide Images
2025
·
A. Zec
, M. Sacco
, et al.
·
Journal of Thoracic Oncology
1935P Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
2025
·
I. Priano
, R. Caro
, et al.
·
Annals of Oncology
PDF
The complementary value of ctDNA and tissue NGS in lung cancer.
2025
·
Patricia Iranzo Gomez
, Gerard Romero-Sola
, et al.
·
Journal of Clinical Oncology
Longitudinal EGFR assessment in plasma and tissue samples in early non–small cell lung cancer (NSCLC).
2025
·
Sara Torresan
, Alex Martinez-Marti
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
12
Citation count:
238
H-index:
5
I10-index:
4
Year
Topic
Type